Published in Nature on March 09, 2011
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Structure of the agonist-bound neurotensin receptor. Nature (2012) 3.23
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure (2011) 2.84
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature (2015) 2.43
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor. Nature (2011) 2.43
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther (2011) 2.13
Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. J Med Chem (2012) 2.10
Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol (2013) 2.06
Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proc Natl Acad Sci U S A (2011) 1.96
Microbial and animal rhodopsins: structures, functions, and molecular mechanisms. Chem Rev (2013) 1.93
Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor. Structure (2012) 1.85
Progress in structure based drug design for G protein-coupled receptors. J Med Chem (2011) 1.82
Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol (2011) 1.75
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling. Cell (2015) 1.68
Lifting the lid on GPCRs: the role of extracellular loops. Br J Pharmacol (2012) 1.50
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. J Biol Chem (2012) 1.48
Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc Natl Acad Sci U S A (2013) 1.46
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science (2015) 1.40
Action of molecular switches in GPCRs--theoretical and experimental studies. Curr Med Chem (2012) 1.40
The significance of G protein-coupled receptor crystallography for drug discovery. Pharmacol Rev (2011) 1.39
Conformational selection or induced fit? 50 years of debate resolved. F1000 Biol Rep (2011) 1.31
The functional cycle of visual arrestins in photoreceptor cells. Prog Retin Eye Res (2011) 1.23
Universal allosteric mechanism for Gα activation by GPCRs. Nature (2015) 1.21
Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nat Commun (2014) 1.16
Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli. Proc Natl Acad Sci U S A (2014) 1.15
The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. Curr Opin Cell Biol (2014) 1.13
Curvature forces in membrane lipid-protein interactions. Biochemistry (2012) 1.09
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. J Virol (2011) 1.07
Conformational dynamics of activation for the pentameric complex of dimeric G protein-coupled receptor and heterotrimeric G protein. Structure (2012) 1.07
Rhodopsin-transducin heteropentamer: three-dimensional structure and biochemical characterization. J Struct Biol (2011) 1.05
Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective. J Mol Biol (2013) 1.05
A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569. J Biol Chem (2012) 1.04
Structure and activation of rhodopsin. Acta Pharmacol Sin (2012) 1.04
Retinal ligand mobility explains internal hydration and reconciles active rhodopsin structures. Biochemistry (2014) 1.01
Bioinformatics and variability in drug response: a protein structural perspective. J R Soc Interface (2012) 1.01
New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Mol Pharmacol (2012) 0.98
Effect of channel mutations on the uptake and release of the retinal ligand in opsin. Proc Natl Acad Sci U S A (2012) 0.97
The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Physiol Rev (2015) 0.97
Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev (2013) 0.97
The rhodopsin-transducin complex houses two distinct rhodopsin molecules. J Struct Biol (2013) 0.96
Overexpression of membrane proteins in mammalian cells for structural studies. Mol Membr Biol (2012) 0.96
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor. J Med Chem (2011) 0.96
Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem (2011) 0.96
Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Rep (2013) 0.95
Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation. FASEB J (2011) 0.95
Molecular dynamics simulations reveal specific interactions of post-translational palmitoyl modifications with rhodopsin in membranes. J Am Chem Soc (2012) 0.95
Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1. Nat Commun (2014) 0.95
Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7. J Biol Chem (2013) 0.95
GPCR agonist binding revealed by modeling and crystallography. Trends Pharmacol Sci (2011) 0.93
Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun (2015) 0.92
Buried ionizable networks are an ancient hallmark of G protein-coupled receptor activation. Proc Natl Acad Sci U S A (2015) 0.92
Site-directed mutations and the polymorphic variant Ala160Thr in the human thromboxane receptor uncover a structural role for transmembrane helix 4. PLoS One (2012) 0.92
Probing Gαi1 protein activation at single-amino acid resolution. Nat Struct Mol Biol (2015) 0.91
G protein-coupled receptors--recent advances. Acta Biochim Pol (2012) 0.90
From atomic structures to neuronal functions of g protein-coupled receptors. Annu Rev Neurosci (2013) 0.90
Signaling by sensory receptors. Cold Spring Harb Perspect Biol (2012) 0.90
Functional map of arrestin-1 at single amino acid resolution. Proc Natl Acad Sci U S A (2014) 0.89
A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor. J Biol Chem (2013) 0.89
GPCR activation: protonation and membrane potential. Protein Cell (2013) 0.89
Structural basis of activation of bitter taste receptor T2R1 and comparison with Class A G-protein-coupled receptors (GPCRs). J Biol Chem (2011) 0.88
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations. Protein Sci (2013) 0.88
Small-molecule antagonists of melanopsin-mediated phototransduction. Nat Chem Biol (2013) 0.88
Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry (2013) 0.88
Ensemble of G protein-coupled receptor active states. Curr Med Chem (2012) 0.88
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region. Nature (2016) 0.87
Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins. Methods (2011) 0.87
Retinal conformation governs pKa of protonated Schiff base in rhodopsin activation. J Am Chem Soc (2013) 0.87
Low aqueous solubility of 11-cis-retinal limits the rate of pigment formation and dark adaptation in salamander rods. J Gen Physiol (2012) 0.87
Molecular details of the activation of the μ opioid receptor. J Phys Chem B (2013) 0.86
Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin. Biochemistry (2011) 0.86
Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. Biochemistry (2013) 0.86
Engineering cells to improve protein expression. Curr Opin Struct Biol (2014) 0.86
Calcium-dependent ligand binding and G-protein signaling of family B GPCR parathyroid hormone 1 receptor purified in nanodiscs. ACS Chem Biol (2013) 0.85
Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations. PLoS Comput Biol (2013) 0.85
Molecular simulations and solid-state NMR investigate dynamical structure in rhodopsin activation. Biochim Biophys Acta (2011) 0.85
Structural, energetic, and mechanical perturbations in rhodopsin mutant that causes congenital stationary night blindness. J Biol Chem (2012) 0.85
Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers. Nat Commun (2012) 0.84
Deconstructing activation events in rhodopsin. J Am Chem Soc (2013) 0.84
Relocating the active-site lysine in rhodopsin and implications for evolution of retinylidene proteins. Proc Natl Acad Sci U S A (2013) 0.83
The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations. PLoS One (2012) 0.83
New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling. Mol Cell Biol (2012) 0.83
Comparative analysis of the heptahelical transmembrane bundles of G protein-coupled receptors. PLoS One (2012) 0.82
MP:PD--a data base of internal packing densities, internal packing defects and internal waters of helical membrane proteins. Nucleic Acids Res (2013) 0.82
Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation. J Biol Chem (2011) 0.82
Structural transitions of transmembrane helix 6 in the formation of metarhodopsin I. J Phys Chem B (2012) 0.82
Structure and function of LGR5: an enigmatic G-protein coupled receptor marking stem cells. Protein Sci (2014) 0.82
Activation mechanism of endothelin ETB receptor by endothelin-1. Nature (2016) 0.82
Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study. Proteins (2011) 0.82
Functional selectivity in GPCR heterocomplexes. Mini Rev Med Chem (2012) 0.81
Engineering of an artificial light-modulated potassium channel. PLoS One (2012) 0.81
Structural biology: snapshot of a signalling complex. Nature (2011) 0.81
Stabilization of G protein-coupled receptors by point mutations. Front Pharmacol (2015) 0.81
Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers. Biochemistry (2013) 0.80
Conformational selection and equilibrium governs the ability of retinals to bind opsin. J Biol Chem (2014) 0.80
Selectivity and activation of dopamine D3R from molecular dynamics. J Mol Model (2012) 0.80
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr (2005) 29.38
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
Crystal structure of opsin in its G-protein-interacting conformation. Nature (2008) 8.61
The structure and function of G-protein-coupled receptors. Nature (2009) 8.08
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature (2008) 7.20
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (1996) 6.50
Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A (2002) 5.91
High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc Natl Acad Sci U S A (2008) 5.06
Crystal structure of squid rhodopsin. Nature (2008) 4.58
Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc Natl Acad Sci U S A (1989) 4.44
Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci U S A (2006) 4.33
Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science (1989) 3.44
Molecular mechanism of 7TM receptor activation--a global toggle switch model. Annu Rev Pharmacol Toxicol (2006) 3.33
Microscale fluorescent thermal stability assay for membrane proteins. Structure (2008) 2.95
Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem (2002) 2.87
Constitutively active mutants of rhodopsin. Neuron (1992) 2.84
Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol (2007) 2.80
Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit. Science (1988) 2.66
Electron crystallography reveals the structure of metarhodopsin I. EMBO J (2004) 2.63
Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc Natl Acad Sci U S A (2002) 2.48
Crystallographic refinement of ligand complexes. Acta Crystallogr D Biol Crystallogr (2006) 2.47
Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. J Mol Biol (2008) 2.47
Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci U S A (2003) 2.21
Arrangement of rhodopsin transmembrane alpha-helices. Nature (1997) 2.10
Engineering G protein-coupled receptors to facilitate their structure determination. Curr Opin Struct Biol (2009) 1.93
Conformations of the active and inactive states of opsin. J Biol Chem (2001) 1.92
Local peptide movement in the photoreaction intermediate of rhodopsin. Proc Natl Acad Sci U S A (2006) 1.92
Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry (1992) 1.91
Potent peptide analogues of a G protein receptor-binding region obtained with a combinatorial library. J Biol Chem (1996) 1.49
Location of the retinal chromophore in the activated state of rhodopsin*. J Biol Chem (2009) 1.48
The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chembiochem (2007) 1.47
An opsin mutant with increased thermal stability. Biochemistry (2003) 1.35
Role of noncovalent binding of 11-cis-retinal to opsin in dark adaptation of rod and cone photoreceptors. Neuron (2001) 1.29
11-cis- and all-trans-retinols can activate rod opsin: rational design of the visual cycle. Biochemistry (2008) 1.03
Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. Biophys J (2007) 1.03
Structural impact of the E113Q counterion mutation on the activation and deactivation pathways of the G protein-coupled receptor rhodopsin. J Mol Biol (2008) 1.02
Dark isomerization of retinals in the presence of phosphatidylethanolamine. Eur J Biochem (1980) 1.01
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
Structure of a beta1-adrenergic G-protein-coupled receptor. Nature (2008) 11.97
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature (2011) 4.31
Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem (2007) 3.07
Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol (2007) 2.80
Electron crystallography reveals the structure of metarhodopsin I. EMBO J (2004) 2.63
New G-protein-coupled receptor crystal structures: insights and limitations. Trends Pharmacol Sci (2008) 2.06
Engineering G protein-coupled receptors to facilitate their structure determination. Curr Opin Struct Biol (2009) 1.93
Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization. Biochim Biophys Acta (2003) 1.90
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature (2010) 1.79
Protein crystallography with a micrometre-sized synchrotron-radiation beam. Acta Crystallogr D Biol Crystallogr (2008) 1.72
Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Proc Natl Acad Sci U S A (2011) 1.59
Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure (2012) 1.55
Development and crystallization of a minimal thermostabilised G protein-coupled receptor. Protein Expr Purif (2009) 1.45
Spectral tuning in the mammalian short-wavelength sensitive cone pigments. Biochemistry (2002) 1.44
An opsin mutant with increased thermal stability. Biochemistry (2003) 1.35
Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge. Proc Natl Acad Sci U S A (2004) 1.32
Opsin activation as a cause of congenital night blindness. Nat Neurosci (2003) 1.25
Preferential interactions of urea with lysozyme and their linkage to protein denaturation. Biophys Chem (2003) 1.16
Stable rhodopsin/arrestin complex leads to retinal degeneration in a transgenic mouse model of autosomal dominant retinitis pigmentosa. J Neurosci (2006) 1.16
Opsin stability and folding: modulation by phospholipid bicelles. J Mol Biol (2007) 1.13
An improved rhodopsin/EGFP fusion protein for use in the generation of transgenic Xenopus laevis. FEBS Lett (2003) 1.12
Crystals of native and modified bovine rhodopsins and their heavy atom derivatives. J Mol Biol (2004) 1.09
Mislocalized rhodopsin does not require activation to cause retinal degeneration and neurite outgrowth in Xenopus laevis. J Neurosci (2006) 1.08
Role of the 9-methyl group of retinal in cone visual pigments. Biochemistry (2004) 1.07
Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry (2003) 1.06
The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J Biol Chem (2003) 1.05
Molecular architecture of a retinal cGMP-gated channel: the arrangement of the cytoplasmic domains. EMBO J (2002) 1.03
Recoverin binds exclusively to an amphipathic peptide at the N terminus of rhodopsin kinase, inhibiting rhodopsin phosphorylation without affecting catalytic activity of the kinase. J Biol Chem (2006) 1.01
Rhodopsin photoproducts in 2D crystals. J Mol Biol (2004) 1.01
Two alternative conformations of a voltage-gated sodium channel. J Mol Biol (2013) 0.99
Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry (2003) 0.98
Production of GPCR and GPCR complexes for structure determination. Curr Opin Struct Biol (2013) 0.98
Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Rep (2013) 0.95
A dark and constitutively active mutant of the tiger salamander UV pigment. Biochemistry (2005) 0.90
Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition. Nanotoxicology (2014) 0.88
Signal transduction: the rhodopsin story continued. Nature (2008) 0.88
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region. Nature (2016) 0.87
X-ray diffraction of heavy-atom labelled two-dimensional crystals of rhodopsin identifies the position of cysteine 140 in helix 3 and cysteine 316 in helix 8. J Mol Biol (2002) 0.87
Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Cell Signal (2013) 0.87
Site-specific differences in gene expression of secreted proteins in the mouse lung: comparison of methods to show differences by location. J Histochem Cytochem (2010) 0.87
Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. J Mol Biol (2004) 0.86
Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin. Biochemistry (2011) 0.86
Opsin stability and folding: the role of Cys185 and abnormal disulfide bond formation in the intradiscal domain. J Mol Biol (2007) 0.84
Relocating the active-site lysine in rhodopsin and implications for evolution of retinylidene proteins. Proc Natl Acad Sci U S A (2013) 0.83
Grafting segments from the extracellular surface of CCR5 onto a bacteriorhodopsin transmembrane scaffold confers HIV-1 coreceptor activity. Structure (2002) 0.83
Rhodopsin photointermediates in two-dimensional crystals at physiological temperatures. Biochemistry (2006) 0.81
Ligands stabilize specific GPCR conformations: but how? Structure (2012) 0.81
Urea unfolding of opsin in phospholipid bicelles. Photochem Photobiol (2009) 0.81
A highly conserved cysteine of neuronal calcium-sensing proteins controls cooperative binding of Ca2+ to recoverin. J Biol Chem (2013) 0.81
Age-specific effects on rat lung glutathione and antioxidant enzymes after inhaling ultrafine soot. Am J Respir Cell Mol Biol (2012) 0.81
Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers. Biochemistry (2013) 0.80
Airway trefoil factor expression during naphthalene injury and repair. Toxicol Sci (2009) 0.79
Pyroglutamate and O-linked glycan determine functional production of anti-IL17A and anti-IL22 peptide-antibody bispecific genetic fusions. J Biol Chem (2012) 0.78
Spial: analysis of subtype-specific features in multiple sequence alignments of proteins. Bioinformatics (2010) 0.78
Adaptation of pineal expressed teleost exo-rod opsin to non-image forming photoreception through enhanced Meta II decay. Cell Mol Life Sci (2011) 0.77
Postnatal exposure history and airways: oxidant stress responses in airway explants. Am J Respir Cell Mol Biol (2012) 0.77
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.77
Structure of β-adrenergic receptors. Methods Enzymol (2013) 0.75
"4D Biology for health and disease" workshop report. N Biotechnol (2010) 0.75
Alzheimer paired helical filaments (PHFs) studied by high-resolution TEM: what can vertical Pt-C replication tell us about the organization of the pronase-digested PHF core? Microsc Res Tech (2005) 0.75
Practical aspects in expression and purification of membrane proteins for structural analysis. Methods Mol Biol (2013) 0.75